Jazz Pharmaceuticals Plc Jazz Pharmaceutical (NASDAQ: JAZZ) Receives FDA Approval for Rylaze Jazz Pharmaceuticals Plc (NASDAQ: JAZZ) disclosed that it has got the authorization of the US FDA for Rylaze. Jazz is allowed to Rylaze as an integral part of a multi-agent chemotherapeutic program.
